Over at Taking Liberties Simon Clark is reviewing ASH Scotland. Here is ASH England’s involvement with Glaxo SmithKline the pharmaceutical company.
Here is Clive Bates of ASH spinning for Glaxo SmithKline:
“The number of people who have died after taking the anti-smoking drug Zyban has more than tripled in a year, official figures show.” Jan 2002
Clive Bates (CB) said “Clive Bates, of Action on Smoking and Health, told BBC News Online said: “Most of these people would have died anyway.”
“The NHS is expected to spend £30 million over two years to provide Zyban..” June 2000
Chris (sic) Bates said: “Chris Bates, director of the anti-smoking charity Action on Smoking and Health (ASH), warned that although Zyban was a “significant development..”
“Niquitin CQ (GlaxoSmithkline) …make nicotine patches and this is the site the gives support for smokers trying to quit.”
ASH very generously to GSK on the 26th June 2000 devote a while press release on GSK’s Zyban drug. 9 months later Bates writes to GSK.
“Clive Bates, Director of ASH said: “Zyban is an effective anti-smoking treatment, and that the first studies show very promising success rates. But until more studies have been done, it is too soon to be making comparisons between NRT and Zyban. Both products have an important role to play and will meet smokers’ needs in different ways. The products may also be most effective when used in combination.”